Access to medicines in under-served countries
Region: -
Country: -
Client: DFID
Date: 2004
Seven studies examining the policy implications of trends in international trade, intellectual property protections and drug registration requirements for emerging producers of generic medicines such as India and China, and for poor people in developing countries. The studies were commissioned by DFID's Access to Medicines Team.
Technical area:
Synthesis report:
Access to medicines in under-served countries: What are the implications of changes in intellectual property rights, trade and drug registration policy? (Druce et al, 2004)
Relevant links:
Willingness and ability to use TRIPs flexibilities: Kenya case study (R. Lewis-Lettington and P. Munyi, 2004)
A survey of policy and practice on the use of access to medicines-related TRIPs flexibilities in Malawi (R. Lewis-Lettington and C. Banda, 2004)
Processes and issues for improving access to medicines: Willingness and ability to utilise TRIPS flexibilities in non-producing countries (B. K. Baker, 2004)
The effect of changing intellectual property on pharmaceutical industry prospects in India and China: considerations for access to medicines (C. Grace, 2004)
Leveraging the Private Sector for Public Health Objectives: A briefing paper for DFID on technology transfer in the pharmaceuticals sector (C. Grace, 2004)
Processes and issues for improving access to medicines: The evidence base for domestic production and greater access to medicines (J. Guimier, E. Lee and M. Grupper, 2004)
Emerging challenges and opportunities in drug registration and regulation in developing countries (S. Hill and K. Johnson, 2004) |